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Introduction 
The complex relationship between the 
hydrodynamic environment and the cultured 
tissue directly impacts on the design and 
production of clinically useful tissue 
engineered (TE) implants [Hutmahcer, 2008]. 
In this work we employed a cost-efficient 
computational approach to determine the 
optimal TE construct location in a perfusion 
bioreactor by using a volume-averaged 
computational fluid dynamic simulation 
(CFD). Subsequently the effect of TE construct 
positioning during perfusion culture on several 
important TE construct quality characteristics 
was experimentally evaluated over time. 
  
Methods 
CFD: For the CFD simulation the scaffold was 
assumed to be a porous medium. The 
Brinkman equation was employed to model 
flow environment in the bioreactor by using 
the Stokes equation for free flow and the 
Darcy law for porous medium flow. 
Experimental: Human periosteum derived cells 
(hPDCS) were culture on Titanium alloy 
(Ti6Al4V) scaffolds in a perfusion bioreactor 
setup. Cell number was determined via DNA 
content analysis by using a highly quantitative 
and selective DNA assay. Gene expression 
analysis  For the determination of the quantity 
and 3D distribution of the ECM throughout the 
TE construct a novel contrast enhanced 
nanoCT (CE-nanoCT) imaging technique was 
employed [Papantoniou, 2013]. 
 
Results 
From the CFD simulations we determined a 
critical length (Lcrit), beyond which a steady 
state laminar flow profile was reached, for a 
range of flow rates. Bioreactor cultures were 
run for TE constructs positioned at the 
bioreactor chamber entrance (Lo) and beyond 
the determined Lcrit. DNA content analysis 
showed a statistically significant increase for 
those scaffolds cultured beyond Lcrit both at 
culture day 14 as well as day 21. For the case 
of Lcrit cultures smaller standard deviations 
were observed between batches for both time 
points. Furthermore, CE-nanoCT analysis 
demonstrated that TE constructs cultured at Lo 
showed lower ECM distribution homogeneity 
but also lower ECM quantity when compared 
to the respective time points of Lcrit cultures.  
 
 
Figure 1:TE construct were positioned at (A) the 
bioreactor entrance (Lo) and (B) above the CFD 
determined length (Lcrit). Live/dead visualization of 
TE constructs for culture day 14 and 21 is shown 
for both cases for cell distribution evaluation. CE-
nanoCT reveals ECM inhomogeneity and lower 
content.for Lo (C) while homogeneity and quantity 
are increased for Lcrit (D). 
 
Discussion 
The non-uniform flow and shear stress profile 
developed for TE constructs at Lo did not 
provide the optimal flow and mass transport 
environment for the cells resulting in TE 
constructs of inferior quality. The volume-
averaged approach used in this work in 
combination with the time-dependent TE 
construct geometric characterization via CE-
nanoCT will provide crucial input for more 
accurate computational modeling, that would 
take into account the gradual change of the 
internal TE construct properties over time.  
 
References 
Hutmacher et al, Trends Biotechnol, 26:166-
172, 2008. 
Papantoniou et al, Tissue Eng: C, Submitted, 
2013. 
